CLL
Clinical trials for CLL explained in plain language.
Never miss a new study
Get alerted when new CLL trials appear
Sign up with your email to follow new studies for CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood cancer combo aims to outperform standard treatment
Disease control OngoingThis study tests whether a new two-drug combination (sonrotoclax plus zanubrutinib) works better than the current standard treatment (venetoclax plus obinutuzumab) for people newly diagnosed with chronic lymphocytic leukemia (CLL), a type of blood cancer. About 652 participants w…
Matched conditions: CLL
Phase: PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists test gentler start for promising leukemia drug
Disease control OngoingThis study is testing new, potentially safer ways to start treatment with an experimental drug called sonrotoclax for adults with chronic lymphocytic leukemia (CLL). The goal is to find the best schedule for slowly increasing the drug dose at the beginning of treatment to reduce …
Matched conditions: CLL
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC